Sequenta Retrospective Analysis Shows ctDNA Superior to CT Scan for Predicting Relapse in Lymphoma Patients Premium The results need to be validated but demonstrate the clinical utility of a more sensitive screen for detecting minimal residual disease. With Sequenta Buy, Adaptive Aims to Combine Immune Sequencing Techs to Develop IVD Kits Premium Adaptive hopes to develop a gold standard for immune sequencing using the combined technologies. Adaptive Biotechnologies Acquires Sequenta Adaptive Biotechnologies CEO Chad Robins will remain as CEO, and Sequenta CEO Tom Willis and CSO Malek Faham will join the senior leadership team. Immunosequencing Comes of Age as Researchers Demo Clinical Utility, Aim for FDA-cleared Products Premium Researchers are demonstrating that sequencing the immune repertoire can offer valuable insight into blood cancers, treatment response, and the likelihood of relapse. Sequenta, Illumina Strike IVD Deal for NGS-based Test to Monitor Residual Disease Sequenta and Illumina have struck an agreement to commercialize an in vitro diagnostic kit based on Sequenta's minimal residual disease detection and quantification technology. Oct 24, 2014 In Brief This Week: Sequenta, Celgene; Thermo Fisher; Quidel, Life Technologies; Hitachi, OpGen; PerkinElmer; Sigma-Aldrich; More Jun 12, 2014 IP Watch: IntegenX, Roche, Hologic, Life Tech, Others Win US Patents Premium Apr 8, 2014 IP Watch: Epigenomics, Fluidigm, Sony, Life Tech, Others Win US Patents Premium Feb 26, 2014 New Tests for Minimal Residual Disease Signal Growing Importance of Prognostic Tools in Leukemia Premium Dec 11, 2013 New Products: Foundation's FoundationOne Heme; InVitae's BRCA Test; Ariosa's Harmony; More Premium Aug 8, 2013 Sequenta Secures Rights to iRepertoire IP for Immune Cell Sequencing Jul 3, 2013 Sequencing MDx Firm Sequenta Raises $20M in Series C Round Jun 12, 2013 Sequenta, Chronix Pursue NGS Tests for Minimal Residual Disease in Cancer Patient Blood Samples Premium Feb 13, 2013 New Products: University of Washington's UW-Onco-Plex; Sequenta's ClonoSight; LifeCodexx's PrenaTest Premium Oct 24, 2012 Sequenta Readies ClonoSight for 2013 Launch with CLIA Certification and Clinical Validation Studies Premium Oct 24, 2012 Sequenta Receives CLIA Certification Aug 17, 2012 In Brief This Week: Myriad Genetics; Sequenta; Dow AgroSciences; EA, Illumina, Golden Helix Aug 15, 2012 Sequenta Tests LymphoSight Assay for Monitoring Residual Disease in Two Clinical Trials Premium Aug 10, 2012 In Brief This Week: Affymetrix, Life Technologies; Genetic Technologies; Luminex; Horizon Discovery, Domainex; Sequenta, SWOG Jan 23, 2012 Sequenta Looks to 2013 for Launch of Sequencing-based Cancer Test Dec 14, 2011 Sequenta Shows its Immune Sequencing Method Can Predict Relapse in Cancer Patients Premium May 24, 2011 HudsonAlpha Researchers to Sequence Immune Repertoires of 10K Individuals for 100 Diseases Premium Mar 22, 2011 Studies Highlight Challenges of Immune Repertoire Sequencing's Clinical Applicability Premium Dec 24, 2010 5AM Solutions Sets Up Shop out West to Tap into Bay Area Life Sciences Market Premium Dec 14, 2010 Sequenta Raises $13M for Development of Immune Repertoire Sequencing-Based Diagnostics Premium Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.